Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs Selaras Citra Nusantara Perkasa Tbk. (SCNP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Diagnos Laboratorium Utama Tbk. vs Selaras Citra Nusantara Perkasa Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp232 (market cap 316.25B, 41.7K 24h volume), while Selaras Citra Nusantara Perkasa Tbk. trades at Rp151 (market cap 375B, 127.5K 24h volume). The key difference: Selaras Citra Nusantara Perkasa Tbk. is the larger of the two by market cap, and Selaras Citra Nusantara Perkasa Tbk. is more actively traded (127.5K versus 41.7K). Which is the better fit depends on your goals.
| DGNS | SCNP | |
|---|---|---|
Market Cap | 316.25B | 375B |
Volume | 41.7K | 127.5K |
Lot | 417 | 1.28K |
Turnover | 9.66M | 19.18M |
Average Price | 231.65 | 150.42 |
Value | 9.66M | 19.18M |
Indicative Equilibrium Price | 230 | 152 |
Indicative Equilibrium Volume | 2.4K | 280 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Diagnos Laboratorium Utama Tbk.
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →About Selaras Citra Nusantara Perkasa Tbk.
PT Selaras Citra Nusantara Perkasa (the Company),located in Bogor, was established based on Notarial Deed of Sukawaty Sumadi, SH. No. 12 dated 24 January 2000. The Company’s commercial operations started in 2000.
Read more on SCNP →
